Have a personal or library account? Click to login
Sanger sequencing of MMR genes in a one-plate system Cover

Sanger sequencing of MMR genes in a one-plate system

By: Lucian Negura and  Anca Negura  
Open Access
|May 2018

References

  1. 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar;136(5):E359-86. DOI: 10.1002/ijc.2921010.1002/ijc.29210
  2. 2. Patel SG, Ahnen DJ. Familial colon cancer syndromes: an update of a rapidly evolving field. Curr Gastroenterol Rep. 2012 Oct;14(5):428-38. DOI: 10.1007/s11894-012-0280-610.1007/s11894-012-0280-6
  3. 3. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78. DOI: 10.3322/caac.2003810.3322/caac.20038
  4. 4. Valean S, Armean P, Resteman S, Nagy G, Muresan A, Mircea PA. Cancer mortality in Romania, 1955-2004. Digestive sites: esophagus, stomach, colon and rectum, pancreas, liver, gallbladder and biliary tree. J Gastrointestin Liver Dis. 2008 Mar;17(1):9-14.
  5. 5. Risch N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):733-41.
  6. 6. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer. 2004 Oct;4(10):769-80. DOI: 10.1038/nrc145310.1038/nrc1453
  7. 7. Lynch HT, Krush AJ. Cancer family “G” revisited: 1895-1970. Cancer. 1971 Jun;27(6):1505-11. DOI: 10.1002/1097-0142(197106)27:6<;1505::AID-CNCR2820270635>3.0.CO;2-L10.1002/1097-0142(197106)27:6<;1505::AID-CNCR2820270635>3.0.CO;2-
  8. 8. Lynch HT, Guirgis HA, Lynch PM, Lynch JF, Harris RE. Familial cancer syndromes: a survey. Cancer. 1977 Apr;39(4 Suppl):1867-81. DOI: 10.1002/1097-0142(197704)39:4+<;1867::AID-CNCR2820390820>3.0.CO;2-Q10.1002/1097-0142(197704)39:4+<;1867::AID-CNCR2820390820>3.0.CO;2-Q
  9. 9. Schlussel AT, Gagliano RA Jr, Seto-Donlon S, Eggerding F, Donlon T, Berenberg J, et al. The evolution of colorectal cancer genetics - Part 1: from discovery to practice. J Gastrointest Oncol. 2014 Oct;5(5):326-35.10.1155/2014/432324
  10. 10. Schlussel AT, Gagliano RA Jr, Seto-Donlon S, Eggerding F, Donlon T, Berenberg J, et al. The evolution of colorectal cancer genetics - Part 2: clinical implications and applications. J Gastrointest Oncol. 2014Oct;5(5):336-44.
  11. 11. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003 Mar;348(10):919-32. DOI: 10.1056/NEJMra01224210.1056/NEJMra012242
  12. 12. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology. 1996 Apr;110(4):1020-7. DOI: 10.1053/gast.1996.v110.pm861298810.1053/gast.1996.v110.pm8612988
  13. 13. Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol. 2014 Aug;109(8):1159-79. DOI: 10.1038/ajg.2014.18610.1038/ajg.2014.186
  14. 14. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 1997 Oct;113(4):1146-58. DOI: 10.1053/gast.1997.v113.pm932250910.1053/gast.1997.v113.pm9322509
  15. 15. Ransohoff DF. Rules of evidence for cancer molecular- marker discovery and validation. Nat Rev Cancer. 2004 Apr;4(4):309-14. DOI: 10.1038/nrc132210.1038/nrc1322
  16. 16. Bedeir A, Krasinskas AM. Molecular diagnostics of colorectal cancer. Arch Pathol Lab Med. 2011 May;135(5):578-87.10.5858/2010-0613-RAIR.1
  17. 17. Cunningham JM, Tester DJ, Thibodeau SN. Mutation detection in colorectal cancers: direct sequencing of DNA mismatch repair genes. Methods Mol Med.2001;50:87-98.10.1385/1-59259-084-5:87
  18. 18. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999 Jun;116(6):1453-6. DOI: 10.1016/S0016-5085(99)70510-X10.1016/S0016-5085(99)70510-X
  19. 19. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 Feb;96(4):261-8. DOI: 10.1093/jnci/djh03410.1093/jnci/djh034
  20. 20. Genuardi M, Anti M, Capozzi E, Leonardi F, Fornasarig M, Novella E, et al. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int J Cancer. 1998 Mar;75(6):835-9. DOI: 10.1002/(SICI)1097-0215(19980316)75:6<;835::AIDIJC4>3.0.CO;2-W10.1002/(SICI)1097-0215(19980316)75:6<;835::AIDIJC4>3.0.CO;2-
  21. 21. Negură A, Matei M, Negură L, Carasevici E, Uhrhammer N, Bignon Y.-J, et al. Ethical implications in communicating molecular tests results to hereditary cancer predisposition families. Revista Romana de Bioetica. 2010 Dec;8(4):74-83.
  22. 22. Negură L, Negura A, Coneac A, Neagoe IB, Azoicai D, Irimie A. Pathogenic intronic and deleterious benign variants: two extremes in cancer predisposition molecular diagnosis. Rev Romana Med Lab. 2012;20(4):317-26.
  23. 23. Negură L, Uhrhammer N, Negură A, Artenie V, Carasevici E, Bignon Y-J. Complete BRCA mutation screening within breast and ovarian cancer predisposition families in North-Eastern Romanian population. Familial Cancer 2010 Dec;9(4):519-23. DOI: 10.1007/s10689-010-9361-610.1007/s10689-010-9361-6
  24. 24. Negură L, Carasevici E, Negură A, Uhrhammer N, Bignon Y-J. Identification of a recurrent BRCA1 mutation in two breast/ovarian cancer predisposition families with distinct phenotypes, by allele-specific multiplex- PCR. Rev Romana Med Lab. 2010;18(2):53-61.
  25. 25. Negură L, Azoicăi D, Matei M, Popoiu G, Negură A. Screening of a novel BRCA2 mutation by rapid in-house PCR-RFLP. Rev Romana Med Lab. 2011;19(4):333-9.
  26. 26. http://primer3.ut.ee/
  27. 27. http://www.genomic.unimelb.edu.au/mdi/mutnomen/
  28. 28. http://www.interactive-biosoftware.com/alamut.html
  29. 29. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005 Sep;294(10):1255-9. DOI: 10.1001/jama.294.10.125510.1001/jama.294.10.1255
  30. 30. Mardis ER. Genome sequencing and cancer. Curr Opin Genet Dev. 2012 Jun;22(3):245-50. DOI: 10.1016/j.gde.2012.03.00510.1016/j.gde.2012.03.005
DOI: https://doi.org/10.2478/rrlm-2018-0008 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 153 - 163
Submitted on: Aug 21, 2017
|
Accepted on: Jan 10, 2018
|
Published on: May 17, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Lucian Negura, Anca Negura, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.